Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
General Atlantic (ALN HLTH), L.P. sold 6,246,096 shares of Alignment Healthcare, Inc. (ALHC) on 09/17/2025 at $16.01 per share in a private placement, reducing the reporting entity's direct holdings to 24,287,227 shares. After the transaction, GA ALN reports indirect additional holdings of 135,716 shares and 18,710 restricted stock units held for two individuals for the benefit of General Atlantic Service Company, L.P. The filing identifies GA ALN and several affiliated General Atlantic funds and entities that may constitute a group but disclaims ownership beyond direct holdings. The Form 4 is signed by Michael Gosk on 09/19/2025.
General Atlantic entities reported a private sale of Alignment Healthcare common stock. On 09/17/2025, General Atlantic (ALN HLTH), L.P. sold 6,246,096 shares of ALHC at $16.01 per share in a private placement to a third party.
After the transaction GA ALN held 24,287,227 shares directly and, including certain shares and restricted stock units held for the benefit of General Atlantic Service Company, L.P., the reporting group beneficially owned 24,596,079 shares indirectly. Multiple General Atlantic affiliated entities are listed as reporting persons and may be deemed members of a group; each disclaimers ownership beyond direct holdings.
Joseph S. Konowiecki, a director of Alignment Healthcare, Inc. (ALHC), reported a non-discretionary sale of 16,076 shares of common stock on 09/16/2025 at a price of $16.24 per share. The sale represents shares withheld to satisfy tax withholding obligations tied to the vesting of restricted stock units and is explicitly described as not a discretionary trade. After the transaction, the reporting person beneficially owned 1,110,973 shares, held directly. The filing discloses routine insider tax-related share withholding rather than an open-market decision to reduce ownership.
General Atlantic (ALN HLTH), L.P. reported an open-market sale of 13,460,000 shares of Alignment Healthcare, Inc. (ALHC) that settled on 09/12/2025 at a net price of $16.01 per share. Following the transaction, GA ALN directly held 30,533,323 shares. The filing reports 30,842,175 shares beneficially owned in total on an indirect basis, which reflects additional shares and restricted stock units held by two individuals for the benefit of General Atlantic Service Company, L.P. The reporting entity is listed as both a director and a 10% owner. The form is signed by Michael Gosk on 09/16/2025.
General Atlantic reported an open-market sale of 13,460,000 shares of Alignment Healthcare (ALHC) common stock settled on 09/12/2025 at a net price of $16.01 per share. After the transaction, General Atlantic (GA ALN) held 30,533,323 shares directly and, when combined with certain shares and restricted stock units held for the benefit of General Atlantic Service Company, L.P., the reporting group is shown as beneficially owning 30,842,175 shares in the filing. The Form 4 identifies multiple related General Atlantic entities and states they may be deemed a group while disclaiming broader beneficial ownership. The filing is signed by Michael Gosk on 09/16/2025 and lists the reporting persons as directors-by-deputization for Section 16 purposes.
Alignment Healthcare, Inc. (ALHC) filed a Form 144 notifying the proposed sale of 13,460,000 shares of common stock through Morgan Stanley & Co. LLC with an aggregate market value of $215,494,600.00. The filing lists the approximate sale date as 09/10/2025 and shows 198,031,417 shares outstanding, implying the proposed sale represents roughly 6.8% of outstanding shares. The securities were acquired on 09/16/2016 in a corporate reorganization involving Alignment Healthcare, Inc., and payment/consideration details reference remarks. No securities sales by the person in the past three months were reported.
Alignment Healthcare, Inc. reports that Chief Legal and Admin. Officer Christopher J. Joyce sold a total of 30,939 shares of common stock on September 10, 2025 in transactions reported as sales in the open market or private transactions at weighted-average prices around $16 per share. After these sales, he directly holds 343,592 shares. A contextual footnote notes that some shares were required to be sold to cover tax withholding obligations related to restricted stock unit vesting and were not discretionary trades.
Robert L. Scavo, Chief Information Officer and director of Alignment Healthcare, Inc. (ALHC), sold shares on 09/10/2025 to satisfy tax withholding from RSU vesting. The filing reports two non-discretionary sales: 21,123 shares at a weighted-average price of $16.2293 (individual trade prices ranged $15.74 to $16.735) and 8,412 shares at a weighted-average price of $16.8555 (individual trade prices ranged $16.74 to $17.24). After these transactions he beneficially owned 580,967 shares following the first set and 572,555 shares following the second set, held directly. The sales were executed pursuant to tax-withholding obligations and were not discretionary trades.
Alignment Healthcare insider sale under 10b5-1 plan; sales were tax-withholding for vested RSUs. On 09/10/2025 Dawn C. Maroney reported three non-discretionary sales of Alignment Healthcare (ALHC) common stock. The reported transactions were: sale of 77,555 shares at a weighted-average price of $16.2293 (per-share sales ranged $15.74–$16.735), sale of 30,884 shares at a weighted-average price of $16.8555 (range $16.74–$17.24), and sales totaling 107,223 shares under a Rule 10b5-1 plan adopted 05/22/2025 at a weighted-average price of $16.4163 (range $16.03–$16.73). Following these transactions the reporting person beneficially owned 1,797,237 shares.
Joseph S. Konowiecki, a director of Alignment Healthcare, Inc. (ALHC), reported a sale of 25,000 shares of the company's common stock on 09/09/2025 at a price of $17 per share. After the reported transaction he beneficially owned 1,127,049 shares, held directly. The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on 03/05/2025, and the Form 4 was signed by an attorney-in-fact on 09/10/2025. The disclosure is limited to this single non-derivative sale and ownership snapshot; no options, acquisitions, or other transactions are reported.